Targeted Strategies for Today's Evolving Markets

MissionIR Blog

The Female Health Co. (FHCO) to Present at the 13th Annual B. Riley & Co. Investor Conference

The Female Health (NASDAQ: FHCO) is the manufacturer and marketer of the patented FC2 Female Condom, available in the United States and approximately 130 other countries throughout the world. FC2 is the only available FDA-approved product that is controlled by a woman to offer dual protection against STDs and unintended pregnancy. FC2 has been cleared by the World Health Organization for purchase by U.N. agencies. For more information, visit the company’s Web site at www.femalehealth.com

B. Riley & Co. provides a full array of corporate finance, research, sales, trading, and otcqx dad services to corporate, institutional, and high net worth clients.  Headquartered in Los Angeles, with offices in San Francisco, New York, and Newport Beach, the firm is recognized for its distinguished equity research, merger and acquisitions advisory services, initial and secondary public offerings, and institutional private placements. For more information on B. Riley & Co., visit www.brileyco.com

Let us hear your thoughts below:

This year's annual B. Riley & Co. Conference will take place on May 20-22, 2013. Bringing together executives from more than 200 companies, the 14th Annual B. Riley & Co. Conference will represent a broad range of consumer and technology sub-sectors. For more information on B. Riley & Co., visit www.brileyco.com.
This entry was posted in B. Riley & Co. Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *